A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older

The 23-valent capsular polysaccharide pneumococcal vaccine (PPSV23) was introduced in Japan’s routine immunization schedule October 2014. It was recommended for adults aged 65 years (including those ≥65 during the transition period), and for adults 60–64 with cardiac, renal, or respiratory dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Kenji, Nakamura, Atsushi, Wakana, Akira, Folaranmi, Temitope A., Iino, Tomoharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482782/
https://www.ncbi.nlm.nih.gov/pubmed/31799889
http://dx.doi.org/10.1080/21645515.2019.1690332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482782/
https://www.ncbi.nlm.nih.gov/pubmed/31799889
http://dx.doi.org/10.1080/21645515.2019.1690332

Ejemplares similares